Thioredoxin-interacting protein deficiency protects against diabetic nephropathy

Journal of the American Society of Nephrology

Volumn 26, Issue 12, 2015, Pages 2963-2977

  Shah, Anu ^a,b,c,d   Xia, Ling ^a,b,d   Masson, Elodie A Y ^a,d   Gui, Chloe ^a,d   Momen, Abdul ^b   Shikatani, Eric A ^b,c   Husain, Mansoor ^b   Quaggin, Susan ^a,d,e   John, Rohan ^b,c   Fantus, I G ^a,b,c,d  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; COLLAGEN TYPE 4; INTERLEUKIN 1BETA; MESSENGER RNA; NEPHRIN; OXYGEN; PROTEIN; PROTEIN F4 80; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SMALL INTERFERING RNA; THIOREDOXIN INTERACTING PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; WILMS TUMOR 1 PROTEIN; CARRIER PROTEIN; CREATININE; CYSTATIN C; DIFFERENTIATION ANTIGEN; GLUCOSE; MEMBRANE PROTEIN; MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGEN; NOX4 PROTEIN, MOUSE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REPRESSOR PROTEIN; STREPTOZOCIN; THIOREDOXIN; TXNIP PROTEIN, MOUSE; WT1 PROTEIN, MOUSE;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EXTRACELLULAR MATRIX; GLOMERULUS BASEMENT MEMBRANE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KIDNEY FIBROSIS; MORPHOMETRICS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; BLOOD; CELL CULTURE; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; FIBROSIS; GENETICS; GLOMERULUS; KNOCKOUT MOUSE; METABOLISM; MITOCHONDRION; PATHOLOGY;

ALBUMINURIA; ANIMALS; ANTIGENS, DIFFERENTIATION; APOPTOSIS; CARRIER PROTEINS; CELLS, CULTURED; COLLAGEN TYPE IV; CREATININE; CYSTATIN C; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; FIBROSIS; GLOMERULAR BASEMENT MEMBRANE; GLUCOSE; INTERLEUKIN-1BETA; KIDNEY GLOMERULUS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MITOCHONDRIA; NADPH OXIDASE; OXIDATIVE STRESS; OXYGEN; PODOCYTES; REPRESSOR PROTEINS; RNA, MESSENGER; STREPTOZOCIN; THIOREDOXINS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84958258840     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014050528     Document Type: Article

References (51)

1. Rask-Madsen C, King GL: Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab 17: 20-33, 2013
2. Dronavalli S, Duka I, Bakris GL: The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab 4: 444-452, 2008
3. Kakehi T, Yabe-Nishimura C: NOX enzymes and diabetic complications. Semin Immunopathol 30: 301-314, 2008
4. Nishikawa T, Edelstein D, Du XL, Yamagishi S,Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000
5. Brownlee M: The pathobiology of diabetic complications: A unifying mechanism. Diabetes 54: 1615-1625, 2005
6. Giacco F, Brownlee M: Oxidative stress and diabetic complications. Circ Res 107: 1058-1070, 2010
7. Wolf G: New insights into the pathophysiology of diabetic nephropathy: Fromhaemodynamics to molecular pathology. Eur J Clin Invest 34: 785-796, 2004
8. Lee HB, YuMR, Yang Y, Jiang Z, Ha H: Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 14 [Suppl 3]: S241-S245, 2003
9. Qi W, Chen X, Gilbert RE, Zhang Y, Waltham M, Schache M, Kelly DJ, Pollock CA: High glucose-induced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1. Am J Pathol 171: 744-754, 2007
10. Perrone L, Devi TS, Hosoya K, Terasaki T, Singh LP: Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions. J Cell Physiol 221: 262-272, 2009
11. Parikh H, Carlsson E,ChutkowWA, Johansson LE, Storgaard H, Poulsen P, Saxena R, Ladd C, Schulze PC, Mazzini MJ, Jensen CB, Krook A, Björnholm M, Tornqvist H, Zierath JR, Ridderstrle M, Altshuler D, Lee RT, Vaag A, Groop LC,Mootha VK: TXNIP regulates peripheral glucose metabolism in humans. PLoS Med 4: e158, 2007
12. Cheng DW, Jiang Y, Shalev A, Kowluru R, Crook ED, Singh LP: An analysis of high glucose and glucosamine-induced gene expression and oxidative stress in renalmesangial cells. Arch Physiol Biochem 112: 189-218, 2006
13. Masson E, Koren S, Razik F, Goldberg H, Kwan EP, Sheu L, Gaisano HY, Fantus IG: High beta-cell mass prevents streptozotocin-induced diabetes in thioredoxin-interacting protein-deficient mice. Am J Physiol Endocrinol Metab 296: E1251-E1261, 2009
14. Saxena G, Chen J, Shalev A: Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein. J Biol Chem 285: 3997-4005, 2010
15. Shah A, Xia L, Goldberg H, Lee KW, Quaggin SE, Fantus IG: Thioredoxininteracting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells. J Biol Chem288: 6835-6848, 2013
16. Chen J, Saxena G, Mungrue IN, LusisAJ, Shalev A: Thioredoxin-interacting protein: A critical link between glucose toxicity and beta-cell apoptosis. Diabetes 57: 938-944, 2008
17. Chen J, Hui ST, Couto FM, Mungrue IN, Davis DB, Attie AD, Lusis AJ, Davis RA, Shalev A: Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cellmass and protects against diabetes. FASEB J 22: 3581-3594, 2008
18. Mussap M, Dalla Vestra M, Fioretto P, Saller A, Varagnolo M, Nosadini R, Plebani M: Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 61: 1453-1461, 2002
19. Kobayashi T, Uehara S, Ikeda T, Itadani H, Kotani H: Vitamin D3 upregulated protein-1 regulates collagen expression in mesangial cells. Kidney Int 64: 1632-1642, 2003
20. Ly J, Alexander M, Quaggin SE: A podocentric view of nephrology. Curr Opin Nephrol Hypertens 13: 299-305, 2004
21. Eid AA, Gorin Y, Fagg BM, Maalouf R, Barnes JL, Block K, Abboud HE: Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes 58: 1201-1211, 2009
22. Spurney RF, Coffman TM: Stressed-out podocytes in diabetes? J Am Soc Nephrol 19: 2035-2037, 2008
23. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, Koide H: Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant 15: 1379-1383, 2000
24. Quaggin SE, Kreidberg JA: Development of the renal glomerulus: Good neighbors and good fences. Development 135: 609-620, 2008
25. Forbes JM, Cooper ME:Mechanisms of diabetic complications. Physiol Rev 93: 137-188, 2013
26. Schroder K, Zhou R, Tschopp J: TheNLRP3 inflammasome: A sensor for metabolic danger? Science 327: 296-300, 2010
27. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J: Thioredoxininteracting protein links oxidative stress to inflammasome activation. Nat Immunol 11: 136-140, 2010
28. Alter ML, Kretschmer A, Von Websky K, Tsuprykov O, Reichetzeder C, Simon A, Stasch JP, Hocher B: Early urinary and plasma biomarkers for experimental diabetic nephropathy. Clin Lab 58: 659-671, 2012
29. Gao P, Meng XF, Su H, He FF, Chen S, Tang H, Tian XJ, Fan D, Wang YM, Liu JS, Zhu ZH, Zhang C: Thioredoxin-interacting protein mediates NALP3 inflammasome activation in podocytes during diabetic nephropathy. Biochim Biophys Acta 1843: 2448-2460, 2014
30. MolitchME,DeFronzo RA, FranzMJ, KeaneWF,MogensenCE, Parving HH, Steffes MW; American Diabetes Association: Nephropathy in diabetes. Diabetes Care 27[Suppl 1]: S79-S83, 2004
31. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993
32. Hamada Y, Fukagawa M: A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy. Kobe J Med Sci 53: 53-61, 2007
33. Tan SM, Zhang Y, Cox AJ, Kelly DJ, Qi W: Tranilast attenuates the upregulation of thioredoxin-interacting protein and oxidative stress in an experimental model of diabetic nephropathy. Nephrol Dial Transplant 26: 100-110, 2011
34. Advani A, Gilbert RE, Thai K, Gow RM, Langham RG, Cox AJ, Connelly KA, Zhang Y, Herzenberg AM, Christensen PK, Pollock CA, Qi W, Tan SM, Parving HH, Kelly DJ: Expression, localization, and function of the thioredoxin system in diabetic nephropathy. J Am Soc Nephrol 20: 730-741, 2009
35. Wu J, Lin H, Liu D, Liu J, Wang N, Mei X, Sun J, Yang G, Zhang X: The protective effect of telmisartan in type 2 diabetes rat kidneys is related to the downregulation of thioredoxin-interacting protein. J Endocrinol Invest 36: 453-459, 2013
36. Castellani LW,Weinreb A, Bodnar J, Goto AM, DoolittleM,Mehrabian M, Demant P, Lusis AJ: Mapping a gene for combined hyperlipidaemia in a mutant mouse strain. Nat Genet 18: 374-377, 1998
37. Kanwar YS,Wada J, Sun L, Xie P, Wallner EI, Chen S, Chugh S, Danesh FR: Diabetic nephropathy: Mechanisms of renal disease progression. Exp Biol Med (Maywood) 233: 4-11, 2008
38. Yoshioka J, Chutkow WA, Lee S, Kim JB, Yan J, Tian R, Lindsey ML, Feener EP, Seidman CE, Seidman JG, Lee RT: Deletion of thioredoxininteracting protein in mice impairs mitochondrial function but protects the myocardium from ischemia-reperfusion injury. J Clin Invest 122: 267-279, 2012
39. Dröge W: Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002
40. Kashihara N, Haruna Y, Kondeti VK, Kanwar YS: Oxidative stress in diabetic nephropathy. Curr Med Chem 17: 4256-4269, 2010
41. Gorin Y, Block K: Nox as a target for diabetic complications. Clin Sci (Lond) 125: 361-382, 2013
42. Gill PS, Wilcox CS: NADPH oxidases in the kidney. Antioxid Redox Signal 8: 1597-1607, 2006
43. Gorin Y, Block K, Hernandez J, Bhandari B, Wagner B, Barnes JL, Abboud HE: Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem 280: 39616-39626, 2005
44. Block K, Gorin Y, Abboud HE: Subcellular localization of Nox4 and regulation in diabetes. Proc Natl Acad Sci U S A 106: 14385-14390, 2009
45. SedeekM, CalleraG,Montezano A, Gutsol A, Heitz F, Szyndralewiez C, Page P, Kennedy CR, Burns KD, Touyz RM, Hébert RL: Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: Implications in type 2 diabetic nephropathy. AmJ Physiol Renal Physiol 299: F1348-F1358, 2010
46. Yoshioka J, Imahashi K, Gabel SA, Chutkow WA, Burds AA, Gannon J, Schulze PC, MacGillivray C, London RE, Murphy E, Lee RT: Targeted deletion of thioredoxin-interacting protein regulates cardiac dysfunction in response to pressure overload. Circ Res 101: 1328-1338, 2007
47. HuangC, LinMZ,ChengD, Braet F, PollockCA, Chen XM: Thioredoxininteracting protein mediates dysfunction of tubular autophagy in diabetic kidneys through inhibiting autophagic flux. Lab Invest 94: 309-320, 2014
48. Zaidi SH, HuangQ,Momen A, Riazi A, HusainM:Growth differentiation factor 5 regulates cardiac repair after myocardial infarction. J Am Coll Cardiol 55: 135-143, 2010
49. Taniguchi K, Xia L, Goldberg HJ, Lee KW, Shah A, Stavar L: E, AYM, Momen, A, Shikatani, EA, John, R, Husain, M, Fantus, IG: Inhibition of Src kinase blocks high glucose-induced EGFR transactivation and collagen synthesis inmesangial cells and prevents diabetic nephropathy in mice. Diabetes 62: 3874-3886, 2013
50. Sanden SK,Wiggins JE, GoyalM, Riggs LK,Wiggins RC: Evaluation of a thick and thin section method for estimation of podocyte number, glomerular volume, and glomerular volume per podocyte in rat kidney with Wilms' tumor-1 protein used as a podocyte nuclear marker. J Am Soc Nephrol 14: 2484-2493, 2003
51. Mallipattu SK, Liu R, Zhong Y, Chen EY, D'Agati V, Kaufman L, Ma'ayan A, Klotman PE, Chuang PY, He JC: Expression of HIV transgene aggravates kidney injury in diabetic mice. Kidney Int 83: 626-634, 2013